TP53 and cancer: These findings not only reveal physiological interactions among TP53, the microbiota, and inflammation but also provide a valid and efficient therapeutic means for treating tp53 mutation-driven inflammation and cancer progression based on manipulating sialometabolism followed by correcting dysbiosis.